相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商:
齐源
- 库存:
9999
- 靶点:
CD274
- 级别:
anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 目录编号:
anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 克隆性:
单克隆
- 抗原来源:
大鼠
- 保质期:
anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 抗体英文名:
GoInVivo™ Purified anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 抗体名:
CD274 (B7-H1, PD-L1) 抗体
- 标记物:
anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 宿主:
大鼠
- 适应物种:
小鼠
- 免疫原:
anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 亚型:
anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 形态:
anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 应用范围:
FC, Block
- 保存条件:
2-8℃
- 浓度:
anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 规格:
5 mg /25 mg/50 mg/100 mg/500 mg/1 g
| 规格: | 5 mg | 产品价格: | ¥14000.0 |
|---|---|---|---|
| 规格: | 25 mg | 产品价格: | ¥43000.0 |
| 规格: | 50 mg | 产品价格: | ¥65000.0 |
| 规格: | 100 mg | 产品价格: | ¥97000.0 |
| 规格: | 500 mg | 产品价格: | ¥335000.0 |
| 规格: | 1 g | 产品价格: | ¥520000.0 |
Description :CD274, also known as B7-H1 or programmed death ligand 1 (PD-L1), is a 40 kD type Itransmembrane protein and a member of the B7 family within the immunoglobulin receptorsuperfamily. It is expressed on T cells, B cells, NK cells, dendritic cells, IFN-γ activatedendothelial cells, and monocytes. B7-H1 is one of the ligands of PD-1. The interaction of B7-H1with PD-1 plays an important role in the inhibition of T cell responses. Other studies haveshown that B7-H1 is able to costimulate T cell growth and cytokine production. CD274 isinvolved in costimulation essential for T cell proliferation and production of IL-10 and IFN-γ, inan IL-2-dependent and a PD-1-independent manner. Its interaction with PD-1 inhibits T cellproliferation and cytokine production.
Verified Reactivity :Mouse
Antibody Type :Monoclonal
Host Species :Rat
Formulation :0.2 µm filtered in phosphate-buffered solution, pH 7.2, containing no preservative. Endotoxinlevel is <1.0 EU/mg of the protein. (<0.1 pg/µg of the protein) as determined by the LAL test.
Preparation :The GoInVivo™ antibody was purified by affinity chromatography
Concentration :The antibody is bottled at the concentration indicated on the vial, typically between 2 mg/mL and3 mg/mL.
Storage & Handling :The antibody solution should be stored undiluted between 2°C and 8°C. This GoInVivo™ solutioncontains no preservative; handle under aseptic conditions.
Application :FC - Quality tested
Block - Reported in the literature, not verified in house
Recommended Usage :Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 µg per million cellsin 100 µL volume or 100 µL of whole blood. It is recommended that the reagent be titrated foroptimal performance for each application.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验1. Maier H, et al. 2007. J. Immunol. 178:2714.
2. Meng Q, et al. 2006. Invest. Ophthalmol. Vis. Sci. 47:4444. PubMed
3. Scarlett UK, et al. 2012. J Exp Med. 209:495. PubMed
4. Grabie N, et al. 2007. Circulation 116:2062. (IF)
5. Paterson AM, et al. 2011. J. Immunol. 187:1097.
6. Channappanavar R, et al. 2012. PLoS One 7:e39757. (Block)
7. Schreiber HA, et al. 2010. PLoS One 5:e11453. (Block) PubMed
8. Muthumani K, et al. 2011. J. Immunol. 187:2932. (Block) PubMed
9. Cripps JG, et al. 2010. Hepatology 52:1350. (Block) PubMed
10. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
11. Riella LV, et al. 2011. Am. J. Transplant 11:832-40. (IHC)
12. Grabie N, et al. 2007. Circulation 116:2062-71. (IHC)
13. Lei GS, et al. 2015. Infect Immun. 83:572. PubMed
Product Citations:
1. Bazan-Peregrino M, et al. 2021. J Immunother Cancer. 9:. PubMed
2. Chen H, et al. 2022. J Immunother Cancer. 10:. PubMed
3. Li D, et al. 2021. Mol Cancer Ther. 20:1926. PubMed
4. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
5. Jaynes JM, et al. 2020. Sci Transl Med. 12:00. PubMed
6. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
7. Janela B, et al. 2019. Immunity. 50:1069. PubMed
8. Wang C, et al. 2018. Sci Transl Med. 10. PubMed
9. Yamazaki K, et al. 2022. Sci Rep. 12:3242. PubMed
流式抗体的选择和配色原则由于在流式细胞实验过程中,荧光抗体对单细胞悬液的标记效果直接影响实验的数据质量。因此,需要考虑各种影响流式抗体品质及检测效果的因素,例如抗体特异性、荧光素信号强弱、荧光素标记方式、同型对照等。本文介绍如何选择合适的流式抗体: 1、需要满足抗体选择的最基本条件:目标蛋白特异性,反应种属以及应用实验等。 靶标特异性:确定标记物名称,确定是细胞表面表达,还是细胞内表达。细胞内表达需要进行透膜。 物种来源:确定待测样本的种属来源。例如,抗小鼠的抗体,不能用于人的样本的检测
,PD-1/PD-L1这么值钱,大家一定好奇它到底是什么鬼。 PD-1全名是程序性死亡分子1(programmed death-1)是Ishida等[1]通过消减杂交技术于1992年发现的[2],是CD28家族成员,胞质区含有2个酪氨酸残基,1个位于靠近N端的免疫受体酪氨酸抑制基序(ITIM)中,另一个1个位于靠近C端的免疫受体酪氨酸转化基序(ITSM)中[2]。 PD-L1(CD274)是B7家族成员,是PD-1的配体,属于1型跨膜蛋白,全长290个氨基酸,包含1个IgV样
细胞形成以及浆细胞抗体的产生。 ②PD-1(CD279),与CTLA-4有24%同源性,胞质区有1个ITIM。PD-1在T细胞呈活化后诱导性表达,其配体为B7―H1/PD-L1(CD274)和B7-DC/PD-L2(CD273),P1)-I与相应配体结合后,胞质区ITIM中酪氨酸发生磷酸化,募集SHP-2,从而抑制T细胞的增殖,抑制IL-2、IL-10和IFN-7等细胞因子的产生,并对B细胞的增殖、分化与Ig分泌及Ig类别转换有抑制作用。 ③BTLA、CD272结构上与CTLA











